- CH₣416.88m
- CH₣632.48m
- CH₣483.90m
- 59
- 50
- 34
- 42
Annual balance sheet for medmix AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 46.2 | 210 | 317 | 112 | 96.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 38.5 | 37.4 | 66.5 | 74.2 | 58.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 155 | 340 | 489 | 308 | 261 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 207 | 230 | 230 | 258 | 262 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 790 | 974 | 1,106 | 1,007 | 954 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 134 | 117 | 271 | 178 | 163 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 457 | 441 | 601 | 542 | 518 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 333 | 534 | 505 | 465 | 436 |
Total Liabilities & Shareholders' Equity | 790 | 974 | 1,106 | 1,007 | 954 |
Total Common Shares Outstanding |